Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Impact of First-Line Consolidative Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Mantle Cell Lymphoma (MCL): A 'Real-World' Study of Treatment Patterns and Outcomes at a Safety-Net Versus a Tertiary Academic Hospital

Heather Reves, Fatima Mahmood, Tanushree Prasad, Akshat M Patel, Aimaz Afrough, Larry D. Anderson, Jr., Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T. Awan, Praveen Ramakrishnan

Blood (2022) 140 (Supplement 1): 13184–13185.

https://doi.org/10.1182/blood-2022-170764

Published: 2022

Journal Articles

Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience

Aishwarya Sannareddy, Heather Reves, Kefyalew Jaleta, Ramyakumari .Ramiahsankarasubramanian, Hetalkumari Patel, Madhusudhanan Narasimhan, Larry D. Anderson, Jr., Aimaz Afrough, Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T. Awan, Alagarraju Muthukumar, Praveen Ramakrishnan Geethakumari

Blood (2022) 140 (Supplement 1): 5203–5205.

https://doi.org/10.1182/blood-2022-171001

Published: 2022

Journal Articles

Treatment Patterns and Outcomes of Peripheral T-Cell Lymphoma (PTCL) Patients Treated at a Safety-Net Hospital Versus a Tertiary Academic Institution: Does Consolidative Autologous Stem Cell Transplantation (ASCT) Make a Difference?

Meredith Jackson, Heather Reves, Tanushree Prasad, Akshat M Patel, Aimaz Afrough, Larry D. Anderson, Jr., Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T. Awan, Praveen Ramakrishnan Geethakumari

Blood (2022) 140 (Supplement 1): 5188–5189.

https://doi.org/10.1182/blood-2022-170517

Published: 2022

Journal Articles

Impact of Bridging Therapy on Infectious Complications Post CAR T-Cell Therapy: The UT Southwestern Experience

Akshat M Patel, Brian Lue, Heather Reves, Aimaz Afrough, Larry D. Anderson, Jr., Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T. Awan, Jeffrey M. Tessier, Praveen Ramakrishnan Geethakumari

Blood (2022) 140 (Supplement 1): 12793–12795.

https://doi.org/10.1182/blood-2022-158778

Published: 2022

Journal Articles

Single-Agent Rituximab and Ultra-Low-Dose Adaptive Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Meredith Jackson, Sean All, Samantha Brocklehurst, Neil B Desai, Jennifer L Shah, Syed M Rizvi, Farrukh T. Awan, Praveen Ramakrishnan Geethakumari, Kiran A Kumar

Blood (2021) 138 (Supplement 1): 4510.

https://doi.org/10.1182/blood-2021-154354

Published: 2021

Journal Articles

Hypofractionated Low-Dose Total Skin Electron Beam Therapy for Primary Cutaneous T-Cell Lymphoma: Analysis of Efficacy and Toxicity

Sofia F Yi, Akshat M Patel, Syed M Rizvi, Praveen Ramakrishnan Geethakumari, Jennifer L Shah, Neil B Desai, Heather W Goff, Kiran A Kumar

Blood (2021) 138 (Supplement 1): 1372.

https://doi.org/10.1182/blood-2021-153958

Published: 2021

Journal Articles

CAR T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A 'Real-World' Analysis of Patterns of Failure and Role of Bridging Therapy

Revathi Ravella, BA, Elizabeth Ren Zhang-Velten, MD PhD, Farrukh T Awan, MD, Syed M Rizvi, MD, Jennifer L Shah, MD, Neil B Desai, MD MHS, Praveen Ramakrishnan Geethakumari, MD MS, Kiran A Kumar, MD MBA

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141445

Published: 2020

Journal Articles

A Radiomic Machine Learning Model to Predict Treatment Response to Methotrexate and Survival Outcomes in Primary Central Nervous System Lymphoma (PCNSL)

Omer M Ali, MD, Sahil S Nalawade, MS, Yin Xi, PhD, Ben Wagner, BM, Alexander Mazal, MD, Shane Ahlers, MD, Syed M Rizvi, MD, Farrukh T Awan, MD, Kiran A Kumar, MD MBA, Neil B Desai, MD MHS, Joseph A Maldjian, MD, Marco C Pinho, MD, Praveen Ramakrishnan Geethakumari, MD MS

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-141941

Published: 2020

Journal Articles

Comparison of Demographics, Treatment Patterns and Outcomes Among Primary Central Nervous System Lymphoma (PCNSL) Patients Treated at a Safety-Net Hospital Versus a Tertiary Academic Institution within the Same Healthcare System

Akshat M Patel, Omer M Ali, MD, Radhika Kainthla, MD, Syed M Rizvi, MD, Farrukh T Awan, MD, Neil B Desai, MD MHS, Robert Timmerman, MD, Kiran A Kumar, MD MBA, Praveen Ramakrishnan Geethakumari, MD MS

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-138568

Published: 2020

Journal Articles

Combined Modality Low-Dose Radiation Therapy (2 Gy x 2) and Single-Agent Rituximab Immunotherapy in the Treatment of Indolent Non-Hodgkin Lymphoma

Samantha Brocklehurst, Neil Desai, MD MHS, Jennifer L Shah, MD, Syed Rizvi, MD, Praveen Ramakrishnan Geethakumari, MD, Kiran A Kumar, MD MBA

Blood (2019) 134 (Supplement_1): 5262.

https://doi.org/10.1182/blood-2019-131246

Published: 2019

Journal Articles

The U1 Spliceosomal RNA: A Novel Non-Coding Hotspot Driver Mutation Independently Associated with Clinical Outcome in Chronic Lymphocytic Leukemia

Blood (2019) 134 (Supplement_1): 847.

https://doi.org/10.1182/blood-2019-130052

Published: 2019

Journal Articles

Successful Field Test of a Combined Health Access Strategy and Novel Device to Screen for Sickle Cell Disease (SCD) in Rural Sub-Saharan Africa

Catherine Mupela Chunda-Liyoka, MD MSc, Ashok A Kumar, PhD BS, MS, Pauline M Sambo, MD, Felicity Lubinda, Tyler Humpton, Pauline Okuku, MSc, Chimuka Miyanda, Bsc, Justine Mulindwa, MD, Judy Im I, Kerry Maguire, MPH, George M Whitesides, Prof., Thomas P. Stossel, MD

Blood (2018) 132 (Supplement 1): 316.

https://doi.org/10.1182/blood-2018-99-114625

Published: 2018

Journal Articles

Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: a novel pathway involving alpha 4 beta 1 integrin receptors on sickle reticulocytes and fibronectin

A Kumar, JR Eckmam, RA Swerlick, TM Wick

Blood (1996) 88 (11): 4348–4358.

https://doi.org/10.1182/blood.V88.11.4348.4348

Published: 1996

Journal Articles

Endotoxin induces downregulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans

T van der Poll, SE Calvano, A Kumar, CC Braxton, SM Coyle, K Barbosa, LL Moldawer, SF Lowry

Blood (1995) 86 (7): 2754–2759.

https://doi.org/10.1182/blood.V86.7.2754.2754

Published: 1995

Journal Articles

Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium

RA Swerlick, JR Eckman, A Kumar, M Jeitler, TM Wick

Blood (1993) 82 (6): 1891–1899.

https://doi.org/10.1182/blood.V82.6.1891.1891

Published: 1993

NARROW

Impact of First-Line Consolidative Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Mantle Cell Lymphoma (MCL): A 'Real-World' Study of Treatment Patterns and Outcomes at a Safety-Net Versus a Tertiary Academic Hospital

Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience

Treatment Patterns and Outcomes of Peripheral T-Cell Lymphoma (PTCL) Patients Treated at a Safety-Net Hospital Versus a Tertiary Academic Institution: Does Consolidative Autologous Stem Cell Transplantation (ASCT) Make a Difference?

Impact of Bridging Therapy on Infectious Complications Post CAR T-Cell Therapy: The UT Southwestern Experience

Single-Agent Rituximab and Ultra-Low-Dose Adaptive Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Hypofractionated Low-Dose Total Skin Electron Beam Therapy for Primary Cutaneous T-Cell Lymphoma: Analysis of Efficacy and Toxicity

CAR T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A 'Real-World' Analysis of Patterns of Failure and Role of Bridging Therapy

A Radiomic Machine Learning Model to Predict Treatment Response to Methotrexate and Survival Outcomes in Primary Central Nervous System Lymphoma (PCNSL)

Comparison of Demographics, Treatment Patterns and Outcomes Among Primary Central Nervous System Lymphoma (PCNSL) Patients Treated at a Safety-Net Hospital Versus a Tertiary Academic Institution within the Same Healthcare System

Combined Modality Low-Dose Radiation Therapy (2 Gy x 2) and Single-Agent Rituximab Immunotherapy in the Treatment of Indolent Non-Hodgkin Lymphoma

The U1 Spliceosomal RNA: A Novel Non-Coding Hotspot Driver Mutation Independently Associated with Clinical Outcome in Chronic Lymphocytic Leukemia

Successful Field Test of a Combined Health Access Strategy and Novel Device to Screen for Sickle Cell Disease (SCD) in Rural Sub-Saharan Africa

Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: a novel pathway involving alpha 4 beta 1 integrin receptors on sickle reticulocytes and fibronectin

Endotoxin induces downregulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans

Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only